Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 3
R&D Momentum
76/100
Pipeline Velocity
42/100
Trial Completion Rate
69/100
Pipeline Concentration
28/100
Pipeline Freshness
54/100
Strategic Signals
Activity
Last 14 days
Exploring the Mediterranean Diet as A Promising Approach for Alleviating Chronic Pain in Sickle Cell Disease
Randomized Pilot Study Evaluating the Effect of a 6-Month Exercise Rehabilitation Program on Physical and Cognitive Function in Persons With MS Who Use Wheelchairs as a Primary Mobility Device
Group Antenatal Care: Effectiveness for Maternal/Infant and HIV Prevention Outcomes and Contextual Factors Linked to Implementation Success in Malawi
FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
Improving Brain-Behavior Markers of Preschool Executive Function Through a Group-Based Parenting Intervention for Low-Income Families
Effects of Delay in Hearing Assistive Technology
Project EMBRACE: Embracing Morning BReakfast and Activity for Classroom Engagement
A Pilot 12 Month, Randomized, Controlled Trial of Curcumin in Kidney Transplant Recipients
A Randomized Control Trial to Improve Metabolic Outcomes in African American Pregnant Women
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)